Edition:
United Kingdom

Retrophin Inc (RTRX.OQ)

RTRX.OQ on NASDAQ Stock Exchange Global Market

23.85USD
23 Feb 2018
Change (% chg)

$1.51 (+6.76%)
Prev Close
$22.34
Open
$23.06
Day's High
$24.09
Day's Low
$22.86
Volume
220,723
Avg. Vol
100,329
52-wk High
$26.43
52-wk Low
$15.57

Select another date:

Mon, Jan 8 2018

BRIEF-Retrophin Expects Total Net Product Sales Of Approximately $155 Million​ In 2018

* ‍FOR FISCAL YEAR 2017, COMPANY EXPECTS TOTAL NET PRODUCT SALES OF APPROXIMATELY $155 MILLION​

BRIEF-Retrophin And Censa Pharmaceuticals Enter Into Strategic Collaboration To Advance Cnsa-001

* RETROPHIN AND CENSA PHARMACEUTICALS ENTER INTO STRATEGIC COLLABORATION TO ADVANCE CNSA-001 FOR THE TREATMENT OF PHENYLKETONURIA (PKU)

BRIEF-Retrophin Enters Into Future Acquisition Right, Joint Development Agreement With Censa Pharma

* RETROPHIN SAYS ON DEC 16, CO ENTERED INTO FUTURE ACQUISITION RIGHT, JOINT DEVELOPMENT AGREEMENT WITH CENSA PHARMA - SEC FILING

BRIEF-Retrophin reports third quarter 2017 financial results

* Q3 earnings per share view $-0.25 -- Thomson Reuters I/B/E/S

Select another date: